Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Phone314-725-4477
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$60.12 billion
Profitability
Miscellaneous
Employees33,700
OptionableOptionable
Centene (NYSE:CNC) Frequently Asked Questions
What is Centene's stock symbol?
Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."
When did Centene's stock split? How did Centene's stock split work?
Centene shares split on Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were distributed to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of Centene stock prior to the split would have 200 shares after the split.
How were Centene's earnings last quarter?
Centene Corp (NYSE:CNC) issued its earnings results on Tuesday, February, 5th. The company reported $1.38 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.33 by $0.05. The business earned $16.56 billion during the quarter, compared to analysts' expectations of $16.38 billion. Centene had a return on equity of 14.10% and a net margin of 1.50%. The firm's revenue for the quarter was up 29.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.49 EPS. View Centene's Earnings History.
When is Centene's next earnings date?
What guidance has Centene issued on next quarter's earnings?
Centene issued an update on its FY19 earnings guidance on Tuesday, February, 5th. The company provided EPS guidance of $8.22-8.62 for the period, compared to the Thomson Reuters consensus estimate of $8.41. The company issued revenue guidance of $70.3-71.1 billion, compared to the consensus revenue estimate of $70.09 billion.Centene also updated its FY 2019 guidance to $4.11-4.31 EPS.
What price target have analysts set for CNC?
15 analysts have issued 1 year price objectives for Centene's stock. Their forecasts range from $71.00 to $87.50. On average, they expect Centene's share price to reach $78.3457 in the next year. This suggests a possible upside of 20.6% from the stock's current price. View Analyst Price Targets for Centene.
What is the consensus analysts' recommendation for Centene?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene.
What are Wall Street analysts saying about Centene stock?
Here are some recent quotes from research analysts about Centene stock:
- 1. According to Zacks Investment Research, "Centene’s fourth-quarter 2018 adjusted earnings per share of $1.38, beat the Zacks Consensus Estimate of $1.33 by 3.8% and improved 42.3% year over year. Solid Health Insurance Marketplace business, purchase of Fidelis Care, expansions and new programs across many states and reinstatement of the health insurer fee drove its revenues. The momentum in revenue growth is likely to grow on the back of rising membership and expansion. The company boasts an impressive inorganic growth strategy driven by buyouts. Medical membership of the company has been rising over the past several quarters due to contract wins. Its shares have outperformed its industry’s gain in a year’s time. However, rising operating costs remains a concern. Also, high debt level increases leverage risk. In 2019, the company expects its adjusted EPS to remain in between $4.11 and $4.31, down from 2018’s full year EPS of $7.08." (2/6/2019)
- 2. Cantor Fitzgerald analysts commented, "We rate Centene Corporation (CNC) DCF-based price target of $145 per share. We continue to view Medicaid as a good growth opportunity. At the same time, CNC is building its Medicare Advantage business, increasing its footprint in individual exchange markets (and doing it profitably) and increasing its specialty offerings. $145 per share 12-month price target is based on DCF analysis." (12/13/2018)
Has Centene been receiving favorable news coverage?
News articles about CNC stock have been trending somewhat positive on Friday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Centene earned a news sentiment score of 1.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
Who are some of Centene's key competitors?
Who are Centene's key executives?
Centene's management team includes the folowing people:
- Mr. Michael Frederic Neidorff, Chairman & CEO (Age 76)
- Ms. Cynthia J. Brinkley, Pres , COO, Chief Admin. & Markets Officer (Age 59)
- Mr. Jeffrey Alan Schwaneke CPA, CPA, Exec., CFO & Treasurer (Age 43)
- Mr. Keith Harvey Williamson, Exec. VP, Gen. Counsel & Corp. Sec. (Age 67)
- Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 43)
Who are Centene's major shareholders?
Centene's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.41%), Oregon Public Employees Retirement Fund (4.77%), Geode Capital Management LLC (0.70%), Northern Trust Corp (0.56%), Dimensional Fund Advisors LP (0.55%) and Jennison Associates LLC (1.05%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Richard A Gephardt, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene.
Which institutional investors are selling Centene stock?
CNC stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Los Angeles Capital Management & Equity Research Inc., Vaughan Nelson Investment Management L.P., Foresters Investment Management Company Inc., Assenagon Asset Management S.A., Bellevue Group AG, Bank of America Corp DE and AGF Investments Inc.. Company insiders that have sold Centene company stock in the last year include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Keith H Williamson, Mark J Brooks, Michael F Neidorff and Robert K Ditmore. View Insider Buying and Selling for Centene.
Which institutional investors are buying Centene stock?
CNC stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Boston Partners, Scout Investments Inc., California Public Employees Retirement System, Geode Capital Management LLC, Amundi Pioneer Asset Management Inc. and Mackenzie Financial Corp. View Insider Buying and Selling for Centene.
How do I buy shares of Centene?
Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Centene's stock price today?
One share of CNC stock can currently be purchased for approximately $64.97.
How big of a company is Centene?
Centene has a market capitalization of $26.68 billion and generates $60.12 billion in revenue each year. The company earns $900 million in net income (profit) each year or $3.54 on an earnings per share basis. Centene employs 33,700 workers across the globe.
What is Centene's official website?
How can I contact Centene?
Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]
MarketBeat Community Rating for Centene (NYSE CNC)
MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
